Counsyl has appointed Ted Snelgrove as its chief business officer. Most recently, Snelgrove was the oncology/hematology business unit head at Jazz Pharmaceuticals. Previously, he built and led the original commercial team at Genomic Health. After his time at Genomic Health, Snelgrove helped build Crescendo Bioscience, now part of Myriad Genetics. He has also served as CEO at Cellspace.